The largest database of trusted experimental protocols

3 protocols using dialysis membrane mwco 12kda

1

Letrozole-Loaded Nanoparticle Formulations

Check if the same lab product or an alternative is used in the 5 most similar protocols
Letrozole was kindly donated by Tofigh Daru (Tehran, Iran). Sorbitan monolaurate (Span20, Cat# S6635), Sorbitan monostearate (Span60, Cat# S7710), Sorbitan monooleate (Span80, Cat# S6760), Cholesterol (CHOL, Cat# C8667), dicetylphosphate (DCP, Cat# 850042P), Sodium dodecyl sulfate (SDS, Cat# L3771) and dialysis membrane (MWCO 12kDa, Cat# D6191), Nile red and Coumarin 6 were obtained from Sigma Aldrich (USA). Dimethyl sulfoxide (DMSO, Cat# 109678), chloroform (Cat# 107024), Amicon (Ultra-15-Membrane, MWCO 30kDa, Cat# C82301) were purchased from Merck (Germany). Trypsin-EDTA (Cat# 15400054), Trypan blue (Cat# 15250061), RPMI-1640 culture medium, DMEM (Dulbecco’s Modified Eagle culture medium, Cat# 11965092), phosphate-buffered saline (PBS, Cat# 10010049), fetal bovine serum (FBS, Cat# 16000044), MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-Diphenyltetrazolium Bromide) (Cat# M6494) and penicillin/streptomycin (PS, Cat# 10378016) 100 X were purchased from Gibco (USA). The MDA-MB-231, MCF-7, and MCF10A cell lines were obtained from Pasteur Cell Bank (Iran). The Annexin V-FITC flow cytometric kit was obtained from Affymetrix Biosciences (USA). RNA extraction and cDNA synthesis kits were purchased from Transgene Biotech, China (Cat#. ER101-01 and AE301-02).
+ Open protocol
+ Expand
2

In Vitro Drug Release from Silver Nanoparticles

Check if the same lab product or an alternative is used in the 5 most similar protocols
In vitro release of MP from the Ag NPs was performed using the dialysis bag method. A dialysis membrane (MWCO 12 kDa, Sigma-Aldrich, St. Louis, MO, USA) was hydrated in distilled water for 24 h. An accurately weighed amount of drug-loaded NPs (equivalent to the amount of MP in ratios of 1:1, 1:3, and 1:6) was dispersed in 10 mL of phosphate buffered saline (PBS) and then transferred to the dialysis bag, which was closed using a plastic clamp. Each bag was placed into a beaker containing 40 mL PBS (pH 7.4, dialysis medium). Aliquots (2 mL) from the dialysis medium were taken for measurements and subsequently replaced at predetermined time intervals with fresh medium. The drug-release study was performed for 24 h. The mean results of triplicate measurements and standard deviations were reported. The solution in the Falcon tube was shaken before each evaluation of UV–visible absorbance. For data analysis, the MP’s maximum absorption band values (λ = 192 nm) were employed. Additionally, drug-only controls (one drug control for each ratio) were made.
+ Open protocol
+ Expand
3

Capecitabine-β-CD Formulation Development

Check if the same lab product or an alternative is used in the 5 most similar protocols
β-CD (purity, >98%) was purchased from Sigma. The drug capecitabine (purity, >99%) was obtained from the Aria Pharmaceutical Company. Acrylic/maleic copolymer (purity, >92%) with a molar mass of 70 000 g mol−1 and brand CP 5 powder were purchased from BASF Germany. Dialysis membrane (MWCO 12 kDa) was purchased from Sigma. All other reagents and chemicals were of analytical grade and purchased from Sigma.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!